All News about Pardes Biosciences, Inc. - Common Stock
Pardes Biosciences Clears IND Application For Oral Antiviral Candidate For COVID-19
February 03, 2022
Via Benzinga
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|
Pardes Biosciences, Inc. - Common Stock (NQ: PRDS )All News about Pardes Biosciences, Inc. - Common Stock
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|